Combination of Gemcitabine and Cisplatin Is Highly Active in Women With Endometrial Carcinoma

Cancer - United States
doi 10.1002/cncr.25498
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Safety and Pharmacokinetics of Motesanib in Combination With Panitumumab and Gemcitabine-Cisplatin in Patients With Advanced Cancer

Journal of Oncology
Oncology
2011English

Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2003English

Comparison of the Efficacy Between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2014English

Chemoimmunotherapy With Brentuximab Vedotin Combined With Ifosfamide, Gemcitabine, and Vinorelbine Is Highly Active in Relapsed or Refractory Classical Hodgkin Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2019English

Curative Resection for Locally Advanced Carcinoma of the Cystic Duct After Downsizing Combination Chemotherapy With Gemcitabine and Cisplatin—Report of a Case—

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2016English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy